Industry News
Pharmaceutical Industry News
Tuesday, the European Council…
Tuesday, the European Council gathered behind new regulations that seek to diversify local biopharma supply chains, support collaborative drug procurement models and devise incentives to bolster drug production in the bloc.
Incyte is strutting its stuff to…
Incyte is strutting its stuff to boost awareness and support for people with vitiligo—with help from supermodel Winnie Harlow.
The U.S. House of Representatives…
The U.S. House of Representatives has given a unanimous thumbs up to the Give Kids A Chance Act, which would revive the FDA’s rare pediatric review voucher program following its expiration in December of last
The manufacturing center of…
The manufacturing center of excellence, proposed in a recent congressional bill, would boost innovation and train workers to bolster production talent throughout the industry.
Could Weight Loss Drugs Turn Fat Cats Into Svelte Ozempets?
GLP-1 drugs for pets could be the next frontier for the blockbuster weight loss and diabetes drugs.
Even as moving tariff targets and…
Even as moving tariff targets and a capricious market have injected uncertainty into the operations of many biopharma players this year, it’s hard to deny the effect that President Donald Trump’s trade duties have had
To Avoid Pharma Tariffs, U.K. Agrees to Trump’s Demand to Pay More for Drugs
President Trump has complained that wealthy countries like Britain pay too little for drugs, leading America to bear much of the burden of the costs of medicines.
The CDC’s vaccine advisory…
The CDC's vaccine advisory committee will meet later this week with a newly promoted chairman in outspoken mRNA critic Kirk Milhoan, M.D., Ph.D., as former chair Martin Kulldorff, Ph.D., moves to a new role in
The lawsuit filed Monday…
The lawsuit filed Monday underscores substantial burdens the one-year test would impose on providers and describes the pilot's rollout as "textbook disregard of administrative law."
The burgeoning field of…
The burgeoning field of transthyretin amyloid cardiomyopathy, which spurred excitement over a potential $20 billion market, may have just revealed the first indication of a slowdown.
Mitsubishi Tanabe Pharma has…
Mitsubishi Tanabe Pharma has undergone a rebrand. Following a 510 billion Japanese yen ($3.3 billion) takeover by Bain Capital, the 350-year-old company has dropped Mitsubishi from its name and those of its affiliates.
Microsize, a U.S.-based CDMO that…
Microsize, a U.S.-based CDMO that specializes in particle size reduction and control technologies, has linked with Switzerland’s Schedio Group to acquire a Lonza micronization facility for an undisclosed price.
Almost exactly a year after…
Almost exactly a year after Omnicom and Interpublic Group announced their plans to merge into the world’s largest advertising agency, their combination is complete.
The FDA is planning to tighten its…
The FDA is planning to tighten its regulations for vaccines, according to an internal email sent by Vinay Prasad, M.D., who heads up the agency’s Center for Biologics Evaluation and Research (CBER).
The Trump administration has lined…
The Trump administration has lined up another country-specific trade agreement, this time with the United Kingdom. The agreement confers Washington’s biggest break on pharmaceutical import tariffs yet.
Extreme Measures for the Fentanyl Crisis
Readers respond to a guest essay about America’s fentanyl problem. Also: A dark echo at Penn.
When communication breaks down in…
When communication breaks down in healthcare, patients suffer. Agentic AI offers a better way.
On the heels of striking a deal…
On the heels of striking a deal with the Trump administration to reduce the prices of several of its most popular drugs for U.S. patients, Eli Lilly has unveiled additional savings for cash-paying users of
The U.S. has revealed price…
The U.S. has revealed price reductions for the second round of prescription drugs negotiated by Medicare through the Inflation Reduction Act (IRA). Headlining the list of 15 treatments that will undergo price reductions in 2027
The company filed its bid for a…
The company filed its bid for a 7.2 mg Wegovy formulation using its National Priority Voucher from the FDA, which promises to accelerate a regulatory review to around one to two months.